OWD
GILD icon

Osborn Williams & Donohoe’s Gilead Sciences GILD Stock Holding History

Osborn Williams & Donohoe’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.62M Buy
35,064
+2,689
+8% +$186K 0.34% 80
2019
Q4 		$2.1M Sell
32,375
-514
-2% -$33.5K 0.21% 111
2019
Q3 		$2.08M Buy
32,889
+6,249
+23% +$408K 0.21% 119
2019
Q2 		$1.8M Sell
26,640
-882
-3% -$58K 0.19% 128
2019
Q1 		$1.82M Buy
27,522
+7,883
+40% +$524K 0.19% 135
2018
Q4 		$1.23M Sell
19,639
-103
-0.5% -$7.2K 0.22% 104
2018
Q3 		$1.52M Sell
19,742
-143
-0.7% -$10.8K 0.24% 102
2018
Q2 		$1.41M Sell
19,885
-437
-2% -$30.9K 0.24% 98
2018
Q1 		$1.53M Sell
20,322
-372
-2% -$29.6K 0.27% 91
2017
Q4 		$1.48M Sell
20,694
-3,952
-16% -$300K 0.25% 92
2017
Q3 		$2M Sell
24,646
-1,689
-6% -$129K 0.36% 79
2017
Q2 		$1.86M Sell
26,335
-12,608
-32% -$839K 0.34% 81
2017
Q1 		$2.65M Sell
38,943
-1,051
-3% -$73.9K 0.48% 62
2016
Q4 		$2.86M Sell
39,994
-7,903
-16% -$587K 0.54% 56
2016
Q3 		$3.79M Sell
47,897
-2,563
-5% -$208K 0.72% 43
2016
Q2 		$4.21M Sell
50,460
-608
-1% -$54K 0.82% 38
2016
Q1 		$4.69M Buy
51,068
+3,562
+7% +$321K 0.94% 35
2015
Q4 		$4.81M Sell
47,506
-5,090
-10% -$530K 0.99% 34
2015
Q3 		$5.27M Buy
52,596
+10,614
+25% +$1.18M 1.14% 32
2015
Q2 		$4.74M Buy
41,982
+27,931
+199% +$3.05M 0.95% 38
2015
Q1 		$1.38M Buy
14,051
+1,020
+8% +$104K 0.27% 88
2014
Q4 		$1.23M Buy
13,031
+2,150
+20% +$222K 0.24% 94
2014
Q3 		$1.16M Buy
10,881
+3,900
+56% +$382K 0.24% 88
2014
Q2 		$619K Sell
6,981
-400
-5% -$31.1K 0.13% 129
2014
Q1 		$523K Sell
7,381
-100
-1% -$7.84K 0.12% 135
2013
Q4 		$562K Hold
7,481
– – 0.13% 133
2013
Q3 		$470K Hold
7,481
– – 0.11% 142
2013
Q2 		$384K Buy
+7,481
New +$390K 0.1% 153

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Osborn Williams & Donohoe's GILD Position: Q1 2020 in Review

Osborn Williams & Donohoe increased its Gilead Sciences (GILD) stake by 8.3% in Q1 2020, buying an estimated $186K and bringing the position to 35,064 shares worth $2.62M. The position accounts for 0.34% of the portfolio, ranked #80.

Osborn Williams & Donohoe first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.27M in Q3 2015. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Osborn Williams & Donohoe held 35,064 shares of Gilead Sciences worth $2.62M as of Q1 2020.
  • Osborn Williams & Donohoe bought 2,689 Gilead Sciences shares in Q1 2020, an estimated $186K.
  • Gilead Sciences made up 0.34% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #80 holding.
  • Osborn Williams & Donohoe first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Gilead Sciences position peaked at $5.27M in Q3 2015.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.